Abstract

Soyasapogenol is a soyasaponin aglycone, which has been suggested to exert a more potent function than the glycoside form. In this study, the effect of soyasapogenol A and B on cultured adipocyte cell function was investigated using mouse 3T3-L1 adipocyte cells. 3T3-L1 cells were treated with insulin, dexamethasone, and 3-isobutyl-1-methylxanthine for differentiation to adipocytes, and the cells were then cultured in the presence of soyasapogenol A or B (6.25 or 12.5 µM). The media were harvested and refreshed every 2 d. After a 10 d culture, the cells were harvested and the triglyceride content of the cells was determined. The triglyceride content of soyasapogenol B-treated cells was significantly lower than those of vehicle-treated cells. Glycerol and free fatty acid levels in the soyasapogenol-treated cell media were higher than those in vehicle cells. However, there was no difference in the level of adipose triglyceride lipase among soyasapogenol A-, soyasapogenol B-, and vehicle-treated cells. The secreted adiponectin and resistin levels of soyasapogenol-treated cell media were also different compared with those of vehicle-treated cells. Especially, the secreted resistin level in soyasapogenol B-treated cell media was obviously reduced compared with that of vehicle-treated cells. Taken together, these results suggest that soyasapogenol B exerted an anti-obesity and anti-diabetic effect on adipocytes by lowering the cellular triglyceride level by accelerating triglyceride lipolysis with reduced resistin secretion.

Highlights

  • Metabolic syndrome (MS) is a group of metabolic factors that are associated with cardiovascular disease and type 2 diabetes [1,2]

  • There was no significant difference in triglyceride level between cells treated with soyasapogenol A or soyasapogenol B at either concentration. 3T3-L1 cell viability was measured using a cell proliferation assay kit

  • These results suggest that soyasapogenol A and B enhanced lipolysis in adipocyte cells and accompanied the reduction of triglycerides in lipid droplets stained by oilred O and that the potency of accelerating lipolysis was higher with soyasapogenol B than it was with soyasapogenol A

Read more

Summary

Introduction

Metabolic syndrome (MS) is a group of metabolic factors that are associated with cardiovascular disease and type 2 diabetes [1,2]. Obesity is linked with the induction of insulin resistance in adipose tissue, which results in several pathologies related to type 2 diabetes. Soybeans have been reported to promote various health functions such as lipid metabolism [6] They include many functional food components, such as soy protein, β-conglycinin, isoflavones, soy peptides [6], lectin, trypsin inhibitor, lecithin, tocopherol, and saponins. Their functional components have been reported to lower cholesterol and triglycerides and to improve lipid metabolism [7,8,9], the exact mechanism of action exerted by those functional components has not been fully elucidated

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.